DE60211917D1 - Alle somatostatinrezeptorsubtypen-bindende somatostatinanaloge und deren verwendung - Google Patents

Alle somatostatinrezeptorsubtypen-bindende somatostatinanaloge und deren verwendung

Info

Publication number
DE60211917D1
DE60211917D1 DE60211917T DE60211917T DE60211917D1 DE 60211917 D1 DE60211917 D1 DE 60211917D1 DE 60211917 T DE60211917 T DE 60211917T DE 60211917 T DE60211917 T DE 60211917T DE 60211917 D1 DE60211917 D1 DE 60211917D1
Authority
DE
Germany
Prior art keywords
present
chelators
amino acid
somatostatin
naphthylalanine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60211917T
Other languages
English (en)
Other versions
DE60211917T2 (de
Inventor
Robert Maecke
Claude Reubi
Hans Rink
Klaus-Peter Eisenwiener
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitaet Bern
Universitaetsspital Basel USB
Original Assignee
Universitaet Bern
Universitaetsspital Basel USB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaet Bern, Universitaetsspital Basel USB filed Critical Universitaet Bern
Application granted granted Critical
Publication of DE60211917D1 publication Critical patent/DE60211917D1/de
Publication of DE60211917T2 publication Critical patent/DE60211917T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60211917T 2001-08-10 2002-08-07 Alle somatostatinrezeptorsubtypen-bindende somatostatinanaloge und deren verwendung Expired - Lifetime DE60211917T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01203033 2001-08-10
EP01203033A EP1283216A1 (de) 2001-08-10 2001-08-10 Alle somatostatinrezeptorsubtypen-bindende Somatostatinanaloge und deren Verwendung
PCT/EP2002/009004 WO2003014158A1 (en) 2001-08-10 2002-08-07 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use

Publications (2)

Publication Number Publication Date
DE60211917D1 true DE60211917D1 (de) 2006-07-06
DE60211917T2 DE60211917T2 (de) 2007-01-18

Family

ID=8180776

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60211917T Expired - Lifetime DE60211917T2 (de) 2001-08-10 2002-08-07 Alle somatostatinrezeptorsubtypen-bindende somatostatinanaloge und deren verwendung

Country Status (12)

Country Link
US (2) US7192570B2 (de)
EP (2) EP1283216A1 (de)
JP (1) JP2005508886A (de)
AT (1) ATE328005T1 (de)
AU (1) AU2002333396B2 (de)
CA (1) CA2456881A1 (de)
CY (1) CY1105177T1 (de)
DE (1) DE60211917T2 (de)
DK (1) DK1419178T3 (de)
ES (1) ES2266616T3 (de)
PT (1) PT1419178E (de)
WO (1) WO2003014158A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1283216A1 (de) * 2001-08-10 2003-02-12 Mallinckrodt Inc. Alle somatostatinrezeptorsubtypen-bindende Somatostatinanaloge und deren Verwendung
SI1603598T1 (sl) * 2003-03-19 2009-02-28 Universitaetsspital Basel Radiooznačeni konjugati na osnovi substance P innjihove uporabe
EP1934251B1 (de) * 2005-10-14 2010-06-16 Stichting Katholieke Universiteit Durch ein oder mehrere standortspezifisch konjugierte hydrazin-nikotin-amid(hynic)-teile markiertes interleukin-8 und seine verwendung zur diagnostizierung von infektionen und entzündungen
PL2076535T3 (pl) 2006-10-16 2013-08-30 Salk Inst Biological Studies Antagoniści somatostatyny selektywni względem receptora (SSTR2)
US8691761B2 (en) * 2006-10-16 2014-04-08 Jean E. F. Rivier Somatostatin receptor 2 antagonists
US8535639B2 (en) 2007-07-17 2013-09-17 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Trifunctional imaging agent for monoclonal antibody tumor-targeted imaging
US11298113B2 (en) 2008-10-01 2022-04-12 Covidien Lp Device for needle biopsy with integrated needle protection
US9782565B2 (en) 2008-10-01 2017-10-10 Covidien Lp Endoscopic ultrasound-guided biliary access system
US8968210B2 (en) 2008-10-01 2015-03-03 Covidien LLP Device for needle biopsy with integrated needle protection
US9186128B2 (en) 2008-10-01 2015-11-17 Covidien Lp Needle biopsy device
US9332973B2 (en) 2008-10-01 2016-05-10 Covidien Lp Needle biopsy device with exchangeable needle and integrated needle protection
GB0903496D0 (en) * 2009-02-27 2009-04-08 Cambridge Entpr Ltd Methods for identification
ES2351569B8 (es) * 2009-05-07 2012-06-20 Bcn Peptides S.A. Ligandos peptídicos de receptores de somatostatina.
GB0922369D0 (en) 2009-12-22 2010-02-03 Hammersmith Imanet Ltd Labelled biotin conjugates
JP2016503402A (ja) * 2012-11-01 2016-02-04 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエＩｐｓｅｎ Ｐｈａｒｍａ Ｓ．Ａ．Ｓ． ソマトスタチン類似体及びそのダイマー
TWI523863B (zh) 2012-11-01 2016-03-01 艾普森藥品公司 體抑素－多巴胺嵌合體類似物
JP6410339B2 (ja) * 2013-03-25 2018-10-24 国立大学法人千葉大学 放射性核種標識オクトレオチド誘導体
KR20180117636A (ko) 2016-02-09 2018-10-29 씨디알디 벤쳐스 인코포레이티드 소마토스타틴 수용체 길항제 화합물 및 이의 이용 방법
AU2018207190B2 (en) 2017-01-12 2020-12-03 Orano Med Treatment of cancer cells overexpressing somatostatin receptors using ocreotide derivatives chelated to radioisotopes
CN108440664A (zh) * 2018-03-27 2018-08-24 上海欣科医药有限公司 一种用于癌症检测的生长抑素类似物及其制备方法和应用
CN112538103B (zh) * 2020-12-28 2022-10-25 合肥科生景肽生物科技有限公司 制备生长激素释放抑制素的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5819669B2 (ja) * 1978-10-28 1983-04-19 白井松新薬株式会社 新規生理活性ペプチド化合物及びその製造法
US5620675A (en) * 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
US6355613B1 (en) * 1996-07-31 2002-03-12 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
US6180082B1 (en) * 1997-11-24 2001-01-30 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method to enhance tissue accumulation of radiolabeled compounds
US6358491B1 (en) * 1999-08-27 2002-03-19 Berlex Laboratories, Inc. Somatostatin analogs
EP1086947A1 (de) * 1999-09-01 2001-03-28 Pfizer Products Inc. Somatostatin Antagonisten und Agonisten, die an der SST Subtyp 2 Rezeptor wirken
EP1283216A1 (de) 2001-08-10 2003-02-12 Mallinckrodt Inc. Alle somatostatinrezeptorsubtypen-bindende Somatostatinanaloge und deren Verwendung

Also Published As

Publication number Publication date
US20070154392A1 (en) 2007-07-05
EP1419178A1 (de) 2004-05-19
PT1419178E (pt) 2006-09-29
ES2266616T3 (es) 2007-03-01
ATE328005T1 (de) 2006-06-15
DK1419178T3 (da) 2006-10-02
US20040242842A1 (en) 2004-12-02
AU2002333396B2 (en) 2008-05-22
JP2005508886A (ja) 2005-04-07
CA2456881A1 (en) 2003-02-20
US7192570B2 (en) 2007-03-20
EP1419178B1 (de) 2006-05-31
US7541018B2 (en) 2009-06-02
WO2003014158A1 (en) 2003-02-20
DE60211917T2 (de) 2007-01-18
CY1105177T1 (el) 2010-03-03
EP1283216A1 (de) 2003-02-12

Similar Documents

Publication Publication Date Title
DE60211917D1 (de) Alle somatostatinrezeptorsubtypen-bindende somatostatinanaloge und deren verwendung
WO2003002489A3 (en) Solid-phase electrophilic fluorination
EP1246621A4 (de) Nitrosierte und nitrosylierte cyclooxygenase-2-inhibitoren, zusammensetzungen und methoden für deren verwendung
HUP0300909A2 (hu) NHE-3 inhibitor hatású 2-guanidino-4-aril-kinazolin-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
PT1003560E (pt) Radioprotector para peptidos marcados com radioisotopos
YU41801A (sh) Derivati fenilglicina
NZ296479A (en) Amino acid or peptide derivatives which are inhibitors of multicatalytic protease (mcp)
MXPA04006581A (es) Derivados de sulfonato y su empleo como acidos latentes.
BR0209434A (pt) Peptìdeos antimicrobianos e composições
MY122262A (en) Lh-rh peptide analogues their uses and pharmaceutical compositions containing them
YU57603A (sh) Inhibitori fosfodiesteraze 4
AU4064597A (en) Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
JP2005508886A5 (de)
DE60104421D1 (de) Prochelators von radiometall markierten molekülen
WO2002081499A3 (en) Somatostatin agonists
AU6854598A (en) 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists
WO2002072602A3 (en) Somatostatin antagonists
ATE242202T1 (de) Peptide
DE60127113D1 (de) Gd3 mimetische peptide
PT1282617E (pt) Derivados de hidantoína com afinidade para os receptores da somatostatina
EP1344828A4 (de) Neue fructosyl-aminosäureoxidase
TR199902055T2 (xx) Kinoksalindiyonlar.
BG103705A (en) Phenoxyacetic acid derivatives and their application as herbicides
EP0924198A3 (de) 3-Mercapto-2-alkyl-alkan-1-ole und ihre Anwendung als Duft- und Aromastoffe
FR2795718B1 (fr) Utilisation de nitriles comme solvants aprotiques polaires

Legal Events

Date Code Title Description
8364 No opposition during term of opposition